Table 2 Association between primary disease and clinicopathological features
Clinical features | RGC-B (n = 57) | RGC-M (n = 61) | P-value |
|---|---|---|---|
Gender | 0.271# | ||
female | 9 (15.79%) | 13 (21.31%) | |
male | 48 (84.21%) | 48 (78.69%) | |
Age (year) | 0.062# | ||
≤ 60 | 21 (36.84%) | 28 (45.90%) | |
> 60 | 36 (63.16%) | 33 (54.10%) | |
Time interval(month) | < 0.001* | ||
151.16 ± 76.30 | 68.05 ± 32.05 | ||
Tumor location | 0.445# | ||
anastomosis | 29 (50.88%) | 31 (50.82%) | |
non-anastomosis | 28 (49.12%) | 30 (49.18%) | |
Tumor Grade | 0.122† | ||
poorly | 37 (64.91%) | 33 (54.10%) | |
moderately | 17 (29.82%) | 21 (34.43%) | |
well | 3 (5.26%) | 7 (11.48%) | |
Tumor size | 0.251# | ||
≤ 3 | 35 (61.40%) | 32 (52.46%) | |
> 3 | 22 (38.60%) | 29 (47.54%) | |
Mean of LN Harvested | < 0.001* | ||
19.86 ± 7.46 | 6.84 ± 6.61 | ||
pT* stage | 0.189† | ||
T1 | 13 (22.81%) | 15 (24.59%) | |
T2 | 7 (12.28%) | 5 (8.20%) | |
T3 | 24 (42.11%) | 23 (37.70%) | |
T4 | 13 (22.81%) | 18 (29.51%) | |
pN* stage | 0.028† | ||
N0 | 23 (40.35%) | 28 (45.90%) | |
N1 | 9 (15.79%) | 18 (29.51%) | |
N2 | 10 (17.54%) | 7 (11.48%) | |
N3 | 15 (26.32%) | 8 (13.11%) | |
TNM stage | 0.387† | ||
Stage 1 | 19 (33.33%) | 20 (32.79%) | |
Stage 2 | 10 (17.54%) | 12 (19.67%) | |
Stage 3 | 28 (49.12%) | 29 (47.54%) |